BioTek Instruments, Inc., announces Paul Held’s promotion to Lab Manager in BioTek’s Applications Laboratory. In this new position, Dr. Held will be responsible for day-to-day lab facilities management, the company’s applications training program and customer visits in addition to his duties as Principal Scientist.
Dr. Held has been with BioTek for over 17 years, and received a PhD in Molecular Biology from Albany Medical College.
"Paul has been an invaluable contributor to the construction, infrastructure acquisition and maintenance of the Applications Lab over its first year," noted Dr. Peter Banks, BioTek’s Scientific Director.
BioTek’s Applications Laboratory partners with major assay developers to provide cutting-edge assay development and validation. Additionally, the lab develops unique applications for BioTek’s microplate instrumentation products in real-lab environments. Many applications developed recently involve cell-based assays using cell lines such as CHO, HEK-293, MCF-7, HepG2, DPX-2, mesothelioma and human primary cells such as hepatocytes and HUVEC. In the past year, over 75 application notes, conference presentations and trade- and peer-reviewed articles have been created towards these goals.
We congratulate Dr. Held as he assumes his new responsibilities.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
For additional information, contact:
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications
908-668-1106 x15
cgriffin@shawtodd.com